• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number S-60-120-120-P6
Device Problems Stretched (1601); Deformation Due to Compressive Stress (2889); Activation Failure (3270); Migration (4003)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/27/2019
Event Type  malfunction  
Manufacturer Narrative
Exemption number (b)(4).The customer reported the device was discarded.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was performed to treat a 75% stenosed and de novo lesion in the right superficial femoral artery (sfa).A 5x120mm supera stent was deployed in the distal sfa.A 6x120mm supera self-expanding stent system (sess) was being deployed by overlapping the first stent; however, due to the puncture being an ipsilateral antegrade, the sheath kinked at the puncture site, and the operability of the sess was reduced.An attempt to recover operability was made, but the stent became elongated and moved.The distal end of the stent moved 2cm away from the proximal end of the first stent; therefore, the overlapping zone disappeared.The proximal end of the stent deployed in the introducer sheath, so the stent was removed with the sess under fluoroscopy.The procedure was successfully completed with a new 6x120mm supera sess.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents and/or complaints from this lot.The investigation determined that the reported difficulties were likely due to case related circumstances.It is likely that the sheath kinked/deformed at the puncture site reduced the operability of the sess causing the stent to stretch and migrate resulting overlapping zone disappeared and proximal end of the stent deployed in the introducer sheath.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9050716
MDR Text Key169516575
Report Number2024168-2019-11799
Device Sequence Number1
Product Code NIP
UDI-Device Identifier08717648211836
UDI-Public08717648211836
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 10/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2020
Device Catalogue NumberS-60-120-120-P6
Device Lot Number8082161
Was Device Available for Evaluation? No
Date Manufacturer Received09/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GUIDE WIRE: ASAHI GLADIUS; GUIDING CATHETER: 6F RADIOFOCUS
-
-